PMA supplement
P110004 S027: NIRxcell CoCr Coronary Stent on RX System
FDA PMA supplement · 135 Review Track For 30-Day Notice · Medinol, Ltd.
Key facts
| Original PMA | P110004 |
|---|---|
| Supplement number | S027 |
| Supplement type | 135 Review Track For 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | NIRxcell CoCr Coronary Stent on RX System |
| Generic name | STENT, CORONARY |
| Applicant | Medinol, Ltd. |
| Product code | MAF |
| Received date | Dec 14, 2017 |
| Decision date | Jun 7, 2018 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: